Taiwan to Announce First Approval of Heated Tobacco Products

Mar.10.2025
Taiwan to Announce First Approval of Heated Tobacco Products
Taiwan's first decision on approval of heated tobacco products expected next month, sparking criticism from anti-smoking groups.

Key points:

 

1. China's Taiwan for the first time has made a resolution on the approval of heated tobacco products, with the results of one manufacturer's application set to be announced as early as next month.

 

2. The Health Promotion Department stated that document reviews and product testing are key processes for evaluation.

 

3. The anti-smoking alliance strongly criticizes the new law.

 


 

Two years after the implementation of the "Amendments to the Tobacco Hazards Prevention Act," Taiwan is set to announce its first decision on whether to approve the sale of heated tobacco products, TaipeiTimes reported on March 8.

 

Wu Chao-chun, Director of the Health Promotion Agency (HPA), said that the amended Tobacco Act provides a case-by-case approval process for the legalization of heated tobacco products. 

 

Currently, 11 tobacco manufacturers have filed appeals with the HPA, with 6 of them completing the document review stage of the approval process.

 

He pointed out that product testing, as the second phase of evaluation, will take six months. He said that the results of an application from a manufacturer will be announced as soon as next month. If the evaluation is successful, the manufacturer will be authorized to legally sell their product with health warnings on the packaging. If the application is not approved, the manufacturer can resubmit the necessary documents to restart the process or challenge the decision through administrative remedies. 

 

Due to varying speeds of processing documents, the announcement of application results will be staggered. Wu added that any deficiencies or unsatisfactory documents must be corrected before the process can continue.

 

The Taiwan Tobacco Control Union criticized the revised law at a press conference. Members of the union pointed out that banning flavored cigarettes by specifically listing prohibited additives is flawed, as tobacco companies can easily circumvent regulations by developing new substances. 

 

In addition, the "health risk assessment" (misnamed by the Health Promotion Administration in the approval process) allows manufacturers to falsely advertise heated products as safer alternatives to cigarettes. They stated that tobacco product sales approval assessments or evaluations should be the correct terms for testing protocols.

 

Lo Su-ying, head of the tobacco control department of the Health Promotion Administration of Taiwan, said that the government has extensively consulted experts and medical professionals in drafting the law. The naming of the agency on the process reflects its aim to scientifically assess the impact of products on public health.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Exclusive: Suspected ‘Backend Update Then Withdrawal’ Suggests Glas May Be Next FDA-Authorized E-Cigarette Brand After Juul
Exclusive: Suspected ‘Backend Update Then Withdrawal’ Suggests Glas May Be Next FDA-Authorized E-Cigarette Brand After Juul
An exclusive 2Firsts investigation found an unpublished FDA update on e-cigarette marketing authorizations that mirrors market speculation, suggesting Glas’s application may have cleared internal review, though no official confirmation has been issued.
Regulations
Dec.21
PMI Launches IQOS ILUMA i in the Philippines, Debuts via Official Stores and Online Channels
PMI Launches IQOS ILUMA i in the Philippines, Debuts via Official Stores and Online Channels
PMFTC, the Philippine affiliate of Philip Morris International (PMI), has introduced the heated tobacco device IQOS ILUMA i in the Philippines, featuring induction-heating technology and multiple smart functions. PMI aims to increase the share of smoke-free products to around 66% of its net revenues by 2030. Previously, PMFTC had already launched ZYN nicotine pouch products in Manila.
Nov.25 by 2FIRSTS.ai
Swedish Oral Pouch Manufacturer WiJo to Establish U.S. Production Base, Targeting March 2026 Start-Up
Swedish Oral Pouch Manufacturer WiJo to Establish U.S. Production Base, Targeting March 2026 Start-Up
Swedish oral pouch manufacturer WiJo Pouches has announced plans to establish its first North American production facility in South Carolina, where it will lease a manufacturing site to produce nicotine, caffeine and functional pouch products. The project, expected to begin operations in March 2026 and create about 170 jobs, has secured tax incentive support from both state and county authorities.
Dec.05 by 2FIRSTS.ai
iMiracle and VPR Reach Preliminary Settlement in ‘Elf’ Trademark Dispute, Potentially Ending Three-Year Legal Battle
iMiracle and VPR Reach Preliminary Settlement in ‘Elf’ Trademark Dispute, Potentially Ending Three-Year Legal Battle
According to Law360, VPR Brands and iMiracle have filed a joint notice in federal court in Florida stating that they have signed a settlement term sheet and plan to finalize a global settlement within 30 days that would resolve multiple lawsuits. The dispute, which began in 2022 and centers on the “Elf” trademark, has involved injunctions, counterclaims and a key ruling by the Federal Circuit overturning a lower court’s order.
Dec.11 by 2FIRSTS.ai
Israel Proposes E-Cigarette Tax Reform Expected to Raise 154 million USD Shekels Annually
Israel Proposes E-Cigarette Tax Reform Expected to Raise 154 million USD Shekels Annually
Israel’s Finance Ministry has proposed a 2026 economic reform introducing new taxes and licensing for e-cigarettes. The plan would impose a NIS 1-per-ml tax on vape liquids and NIS 30 per device, abolish VAT exemptions in Eilat, and is expected to generate about NIS 500 million(154 million USD) annually.
Nov.10 by 2FIRSTS.ai
Malaysia Collected US$50.07 million in Vape Tax Since April 2023
Malaysia Collected US$50.07 million in Vape Tax Since April 2023
Malaysia collected RM209.5 million(US$50.07 million) in excise duty on nicotine-containing vape liquids and gels from April 2023 to August 2025, according to Finance Ministry data. However, Health Minister Dr Dzulkefly Ahmad said RM223.5 million was spent treating EVALI patients in the past year alone, exceeding the tax revenue.
Nov.06 by 2FIRSTS.ai